Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06991127 · ClinicalTrials.gov registry record · NA

Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection

A NA study of Healthy Eyes, sponsored by Centervue SpA.

Recruiting
Registry status
NA
Development phase
380
Enrollment target
3
Study locations

NCT06991127: Recruiting NA study of Healthy Eyes, sponsored by Centervue SpA.

NCT06991127 is a NA study of Healthy Eyes that is actively recruiting participants, run by Centervue SpA. The registered enrollment target is 380 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06991127, a NA study of Healthy Eyes, is actively recruiting participants, sponsored by Centervue SpA.

RECRUITING
Registry status
NA
Development phase
380 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this pre-market, multicentric cross-sectional study is to create a mesopic Normative Database for a new version of the MAIA device. Moreover, the study aims to evaluate MAIA safety and adverse events. These purposes will be achieved by collecting data of healthy subjects, who will undergo microperimetric examinations with the MAIA device during one single visit.

Conditions Studied

Interventions

  • DEVICE MAIA

Study Locations (3)

Florida

  • The Eye Care Institute - Fort Lauderdale

Western Australia

  • UWA Eye Health Centre of Western Australia - Perth

Switzerland

  • Universitätsspital Basel, Augenklinik - Basel

Trial Details

FieldValue
Enrollment Target 380 participants
Start Date 2025-04-23
Est. Completion 2026-06-01
Phase NA

Sponsor

Centervue SpA

1 total trials

What the Registry Record Tells You About NCT06991127

The ClinicalTrials.gov registry entry for NCT06991127 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centervue SpA, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Eyes appearing as the primary indexed condition, and to 1 intervention - of which MAIA is the first listed.

NCT06991127 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Western Australia, Switzerland.

Frequently Asked Questions

What is clinical trial NCT06991127 about?

NCT06991127 is a clinical study titled "Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection". The purpose of this pre-market, multicentric cross-sectional study is to create a mesopic Normative Database for a new version of the MAIA device. Moreover, the study aims to evaluate MAIA safety and adverse events. These purposes will be achieved by collecting data of healthy subjects, who will und...

What is the current status of trial NCT06991127?

This trial is currently recruiting. It is a NA study. The enrollment target is 380 participants. The study started on 2025-04-23. Estimated completion is 2026-06-01.

What conditions does trial NCT06991127 study?

This clinical trial studies the following conditions: Healthy Eyes.

What interventions are being tested in trial NCT06991127?

The interventions under investigation include: MAIA (DEVICE).

Who is sponsoring clinical trial NCT06991127?

This trial is sponsored by Centervue SpA, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06991127 being conducted?

This trial has 3 study locations across Florida, Western Australia, Switzerland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Eyes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.